What Dental Leaders Are Optimistic About for 2026

Bypaulgruensfelder
Becker’s Dental Review December 17, 2025
Read Full Article →
AI-Generated Summary

Dental leaders are bullish on dentist-led group practice platforms, clinical technology (CBCT, laser), AI integration, and procurement solutions that can offset rising costs. Several describe 2026 as the beginning of an “efficiency renaissance” where technology becomes central to how practices compete. The optimism is grounded in operational improvement, not just market conditions.

Why It Matters

For DSO operators, this piece highlights where peers are investing for competitive advantage — useful for benchmarking technology and procurement priorities.

dental industry outlook technology adoption group practice CBCT AI procurement DSO strategy

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Similar Posts

  • Google I/O 2026: What’s next for SEO?

    Bypaulgruensfelder

    Google announced its biggest search shift in 25 years at I/O 2026 — an AI-powered search experience with a redesigned conversational search box, personal intelligence features, and new guidance on optimization for AI-driven results. BrightLocal assembled expert commentary from Rachel Ellen (Croud), Myles Anderson (BrightLocal), Celeste Gonzalez (Lastmile Retail), and David Mihm (Near Media) on what the changes mean for local businesses. The consensus: SEO fundamentals still hold, but businesses must now also prepare for agentic AI that books appointments and completes transactions on behalf of users.

  • Mayo Clinic and Microsoft Are Building a Frontier AI Model for Healthcare

    Bypaulgruensfelder

    Mayo Clinic and Microsoft announced a strategic collaboration on June 2, 2026 to build a frontier AI model purpose-built for healthcare. The model combines Mayo’s de-identified clinical data and longitudinal insights with Microsoft’s AI, cloud, and engineering capabilities to synthesize diverse clinical data for earlier diagnoses, more personalized treatment decisions, and better patient outcomes. Unlike general-purpose models, it is designed for deep clinical context, rigorous governance, and real-world validation, and will be deployed first inside Mayo’s trusted clinical environment. The frontier model will be owned by Mayo Clinic, and Microsoft plans to distribute it through Azure Foundry APIs so organizations worldwide can access advanced healthcare AI capabilities.

  • Five Forces Shaping Dental Tech in 2026: Revere Partners’ Mid-Year View

    Bypaulgruensfelder

    Dental care demand is resilient—Americans spent $189 billion in 2024, tied for the highest annual total this century—but delivery margins are the tightest in years, a dynamic the ADA Health Policy Institute calls a “fiscal squeeze.” Revere Partners identifies five forces reshaping oral health in 2026: efficiency software as the only fully controlled margin lever amid labor shortages; a widening case-acceptance gap, with nearly half of practices converting just 40–70% of treatment plans; FDA-cleared clinical AI becoming table stakes as dental tech funding hit roughly $2.1 billion in 2025; private-equity consolidation moving upmarket into specialties trading at 8–15x EBITDA; and new state M&A scrutiny like California’s AB 1415 turning compliance into a growth vertical.

  • The Healthcare Citation Share Index 2026: Mayo Clinic Leads AI Answers

    Bypaulgruensfelder

    Mayo Clinic leads all healthcare brands in AI citation share at 9.4, ahead of Cleveland Clinic (7.1) and Johns Hopkins Medicine (6.8), according to Everything-PR’s Healthcare Citation Share Index 2026. The study scored 75+ queries across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews using a five-component formula weighted toward citation frequency (40%) and cross-engine breadth (20%). The top three hospital systems alone capture 23.3% of total healthcare citation share — more than the entire pharma category combined. Consumer health platforms like WebMD and Healthline also outrank every individual pharma brand, while Epic Systems holds a 6x citation lead over Oracle Health among EHR vendors.

  • Health services M&A is active in 2026, but uncertainty slows volume: PwC

    Bypaulgruensfelder

    Healthcare M&A deal value surged in early 2026 — $18 billion in Q1 and $11 billion through May in Q2 — far outpacing H1 2025 totals, according to a new PwC analysis. But deal volume has softened as buyers grow more selective amid reimbursement uncertainty and Medicaid funding pressure from the “Big Beautiful Bill.” PwC finds investors are prioritizing assets with strong margin profiles, scalable operations, and proven financial returns. AI tools remain attractive to dealmakers but must demonstrate hard-dollar ROI: “Pilot-stage claims no longer justify valuation uplift.” Revenue cycle management and clinical documentation AI are showing the strongest returns.

  • Ascension’s $3.9B AmSurg Deal Signals New ASC Antitrust Era

    Bypaulgruensfelder

    Ascension completed its $3.9 billion acquisition of AmSurg on June 4, 2026, expanding its ambulatory surgery center network from 58 to more than 300 facilities across 34 states — making it one of the largest ASC operators in the U.S. alongside Tenet’s USPI and SCA Health. The FTC required Ascension to divest seven ASCs in Tennessee, Florida, Oklahoma, Texas, and Kansas to preserve local competition, with six going to SCA Health (an Optum subsidiary) and one transferring to a physician group. For 10 years, Ascension must give the FTC advance notice before acquiring any ASCs near the divested markets. The consent order marks the first time the FTC has scrutinized an ASC deal at this scale, signaling new antitrust attention on outpatient surgery consolidation.